Literature DB >> 87202

Kinetics of phosphorylation of 5-aza-2'-deoxyycytidine by deoxycytidine kinase.

R L Momparler, D Derse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87202     DOI: 10.1016/0006-2952(79)90454-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  19 in total

1.  Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.

Authors:  J L Abbruzzese; P Frost
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

Authors:  W J Moriconi; M Slavik; S Taylor
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

3.  Simultaneous quantitative determination of 5-aza-2'-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors.

Authors:  Nicole M Anders; Jianyong Liu; Teresia Wanjiku; Hugh Giovinazzo; Jianya Zhou; Ajay Vaghasia; William G Nelson; Srinivasan Yegnasubramanian; Michelle A Rudek
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-03-21       Impact factor: 3.205

4.  Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine.

Authors:  R L Momparler; J Samson; L F Momparler; G E Rivard
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line.

Authors:  S Bartolucci; M Estenoz; V de Franciscis; P Carpinelli; G L Colucci; G Augusti Tocco; M Rossi
Journal:  Cell Biophys       Date:  1989 Aug-Oct

6.  Feasibility of therapy with hypomethylating agents in patients with renal insufficiency.

Authors:  G Nicolas Batty; Hagop Kantarjian; Jean-Pierre Issa; Elias Jabbour; Fabio P S Santos; Deborah McCue; Guillermo Garcia-Manero; Sherry Pierce; Susan O'Brien; Jorge E Cortés; Farhad Ravandi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-06

Review 7.  Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.

Authors:  Jonathan C Cheng; Daniel J Weisenberger; Felicidad A Gonzales; Gangning Liang; Guo-Liang Xu; Ye-Guang Hu; Victor E Marquez; Peter A Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Chemical decomposition of 5-aza-2'-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry.

Authors:  Daniel K Rogstad; Jason L Herring; Jacob A Theruvathu; Artur Burdzy; Christopher C Perry; Jonathan W Neidigh; Lawrence C Sowers
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

10.  Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.

Authors:  R L Momparler; L F Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.